PIMAFUCIN
20MG/G CRM 30G
SÚKL code | 0211845 |
---|---|
Name of the product | PIMAFUCIN |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | PIMAFUCIN |
Supplement | 20MG/G CRM 30G |
Strenght | 20MG/G |
Pharmaceutical form | Cream |
Package | 30G |
Route | Cutaneous use |
Language of the pack | Czech |
Wrap type | Tube |
Legal status | na lékařský předpis |
Active substance | NATAMYCIN (NATAMYCINUM) |
ATC group | D01AA02 |
ATC group name | NATAMYCIN |
Marketing authorisation information
Registration Number | 26/ 160/71-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 28. 02. 2022 |
MA Holder | LEO Pharma A/S, Ballerup |
MA Holder country | DÁNSKO |
Actual MA holder | CHEPLAPHARM Arzneimittel GmbH, Greifswald |
Actual MA holder country | NĚMECKO |